Fulgent Genetics, Inc. (FLGT)
NASDAQ: FLGT · IEX Real-Time Price · USD
+0.22 (1.10%)
Jun 21, 2024, 4:00 PM EDT - Market closed

Fulgent Genetics Revenue

Fulgent Genetics had revenue of $287.53M in the twelve months ending March 31, 2024, down -21.20% year-over-year. Revenue in the quarter ending March 31, 2024 was $64.49M, a -2.54% decrease year-over-year. In the year 2023, Fulgent Genetics had annual revenue of $289.21M, a decrease of -53.27%.

Revenue (ttm)
Revenue Growth
P/S Ratio
Revenue / Employee
Market Cap
606.57M USD

Revenue Chart


Fiscal Year End Revenue Change Growth
Dec 31, 2023289.21M-329.76M-53.27%
Dec 31, 2022618.97M-373.62M-37.64%
Dec 31, 2021992.58M570.87M135.37%
Dec 31, 2020421.71M389.18M1,196.46%
Dec 31, 201932.53M11.18M52.35%
Dec 31, 201821.35M2.62M13.99%
Dec 31, 201718.73M454.00K2.48%
Dec 31, 201618.28M8.70M90.85%
Dec 31, 20159.58M8.30M649.30%
Dec 31, 20141.28M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Castle Biosciences 250.73M
Weave Communications 178.08M
National Research 147.42M
Surmodics 142.96M
UroGen Pharma 84.30M
Zymeworks 50.46M
Revenue Rankings